BIONXT SOLUTIONS INC (BNXTF:OTCMKTS)

$0.2971 -0.0083 (-2.7177%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 77

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) News Sources

BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis

17-02-2026

yahoo.com

external link

BioNxt Announces Closing of Shares for Debt Settlement

27-02-2026

yahoo.com

external link

BioNxt Signs Strategic Agreement for Eurasian Commercialization Following Cladribine ODF Patent Grant in Eurasia and Europe

17-03-2026

yahoo.com

external link

BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform

24-03-2026

yahoo.com

external link

BioNxt Advances Semaglutide as First Application of Broad GLP-1 ODF Platform Strategy

30-03-2026

yahoo.com

external link

BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries

07-04-2026

yahoo.com

external link

BioNxt Solutions Registers Its ODF Platform With the European Patent Office

07-04-2026

yahoo.com

external link

BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)

14-04-2026

yahoo.com

external link

BioNxt Applies Advanced Drug Delivery Strategy and Psychedelic Compound Library to Emerging Therapeutics Market Amid Accelerating Global Momentum

28-04-2026

yahoo.com

external link

BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development

19-05-2026

yahoo.com

external link

BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) Sentiment Trend

0 25 50 75 100 73 52 76 85 85 76 85 69 85 86 17-02-2026 27-02-2026 17-03-2026 24-03-2026 30-03-2026 07-04-2026 14-04-2026 28-04-2026 19-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) FAQs

toggle

What is the current price of BIONXT SOLUTIONS INC (BNXTF:OTCMKTS)?

The current price of BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) is $0.2971.


toggle

BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) since the previous trading day is $-0.0083.


toggle

BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) since the previous trading day is -2.7177%.


toggle

What is the most recent average sentiment score for BIONXT SOLUTIONS INC (BNXTF:OTCMKTS)?

The most recent average sentiment score for BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) is 77 out of 100.


toggle

What is the most recent average sentiment for BIONXT SOLUTIONS INC (BNXTF:OTCMKTS)?

The most recent sentiment for BIONXT SOLUTIONS INC (BNXTF:OTCMKTS) is .


SEC-8K** Filing Available For BIONXT SOLUTIONS INC (BNXTF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

BNET (Bion Environmental Technologies Inc)
BTTX (Better Therapeutics Inc)
BTAX (Biostax Corp)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.